Skip to main content
Top
Published in: Thrombosis Journal 1/2013

Open Access 01-12-2013 | Original clinical investigation

Variability between laboratories performing coagulation tests with identical platforms: a nationwide evaluation study

Authors: Michael Nagler, Lucas M Bachmann, Lorenzo Alberio, Anne Angelillo-Scherrer, Lars M Asmis, Wolfgang Korte, Adriana Mendez, Guido Reber, Hans Stricker, Dimitrios A Tsakiris, Walter A Wuillemin

Published in: Thrombosis Journal | Issue 1/2013

Login to get access

Abstract

Background

While the assessment of analytical precision within medical laboratories has received much attention in scientific enquiry, the degree of as well as the sources causing variation between them remains incompletely understood. In this study, we quantified the variance components when performing coagulation tests with identical analytical platforms in different laboratories and computed intraclass correlations coefficients (ICC) for each coagulation test.

Methods

Data from eight laboratories measuring fibrinogen twice in twenty healthy subjects with one out of 3 different platforms and single measurements of prothrombin time (PT), and coagulation factors II, V, VII, VIII, IX, X, XI and XIII were analysed. By platform, the variance components of (i) the subjects, (ii) the laboratory and the technician and (iii) the total variance were obtained for fibrinogen as well as (i) and (iii) for the remaining factors using ANOVA.

Results

The variability for fibrinogen measurements within a laboratory ranged from 0.02 to 0.04, the variability between laboratories ranged from 0.006 to 0.097. The ICC for fibrinogen ranged from 0.37 to 0.66 and from 0.19 to 0.80 for PT between the platforms. For the remaining factors the ICC’s ranged from 0.04 (FII) to 0.93 (FVIII).

Conclusions

Variance components that could be attributed to technicians or laboratory procedures were substantial, led to disappointingly low intraclass correlation coefficients for several factors and were pronounced for some of the platforms. Our findings call for sustained efforts to raise the level of standardization of structures and procedures involved in the quantification of coagulation factors.
Appendix
Available only for authorised users
Literature
1.
go back to reference Marshall WJ, Bangert SK, Lapsley M: The clinical utility of laboratory investigations. In Clinical Chemistry. Philadelphia, PA: Mosby Elsevier; 2012:9. volume 7 Marshall WJ, Bangert SK, Lapsley M: The clinical utility of laboratory investigations. In Clinical Chemistry. Philadelphia, PA: Mosby Elsevier; 2012:9. volume 7
2.
go back to reference NCCLS: Evaluation of Precision Performance of Clinical Chemistry Devices; Approved Guideline. Wayne, PA: NCCLS; 1999. NCCLS: Evaluation of Precision Performance of Clinical Chemistry Devices; Approved Guideline. Wayne, PA: NCCLS; 1999.
3.
go back to reference Miller WG, Jones GR, Horowitz GL, Weykamp C: Proficiency testing/external quality assessment: current challenges and future directions. Clin Chem 2011, 57: 1670-1680. 10.1373/clinchem.2011.168641CrossRefPubMed Miller WG, Jones GR, Horowitz GL, Weykamp C: Proficiency testing/external quality assessment: current challenges and future directions. Clin Chem 2011, 57: 1670-1680. 10.1373/clinchem.2011.168641CrossRefPubMed
4.
go back to reference Spannagl M, Dick A, Reinauer H: External quality assessment schemes in coagulation in Germany: between regulatory bodies and patient outcome. Semin Thromb Hemost 2007, 33: 259-264. 10.1055/s-2007-971812CrossRefPubMed Spannagl M, Dick A, Reinauer H: External quality assessment schemes in coagulation in Germany: between regulatory bodies and patient outcome. Semin Thromb Hemost 2007, 33: 259-264. 10.1055/s-2007-971812CrossRefPubMed
5.
go back to reference Plebani M, Sanzari MC, Zardo L: Quality control in coagulation testing. Semin Thromb Hemost 2008, 34: 642-646. 10.1055/s-0028-1104542CrossRefPubMed Plebani M, Sanzari MC, Zardo L: Quality control in coagulation testing. Semin Thromb Hemost 2008, 34: 642-646. 10.1055/s-0028-1104542CrossRefPubMed
6.
go back to reference Cuker A, Raby A, Moffat KA, Flynn G, Crowther MA: Interlaboratory variation in heparin monitoring: Lessons from the Quality Management Program of Ontario coagulation surveys. Thromb Haemost 2010, 104: 837-844. 10.1160/TH10-02-0099CrossRefPubMed Cuker A, Raby A, Moffat KA, Flynn G, Crowther MA: Interlaboratory variation in heparin monitoring: Lessons from the Quality Management Program of Ontario coagulation surveys. Thromb Haemost 2010, 104: 837-844. 10.1160/TH10-02-0099CrossRefPubMed
7.
go back to reference Favaloro EJ, Bonar R, Kershaw G, Duncan E, Sioufi J, Marsden K: Investigations from external quality assurance programs reveal a high degree of variation in the laboratory identification of coagulation factor inhibitors. Semin Thromb Hemost 2009, 35: 794-805. 10.1055/s-0029-1245112CrossRefPubMed Favaloro EJ, Bonar R, Kershaw G, Duncan E, Sioufi J, Marsden K: Investigations from external quality assurance programs reveal a high degree of variation in the laboratory identification of coagulation factor inhibitors. Semin Thromb Hemost 2009, 35: 794-805. 10.1055/s-0029-1245112CrossRefPubMed
8.
go back to reference Meijer P, Haverkate F: External quality assessment and the laboratory diagnosis of thrombophilia. Semin Thromb Hemost 2005, 31: 59-65. 10.1055/s-2005-863806CrossRefPubMed Meijer P, Haverkate F: External quality assessment and the laboratory diagnosis of thrombophilia. Semin Thromb Hemost 2005, 31: 59-65. 10.1055/s-2005-863806CrossRefPubMed
9.
go back to reference Shahangian S, Labeau KM, Howerton DA: Prothrombin time testing practices: adherence to guidelines and standards. Clin Chem 2006, 52: 793-794. 10.1373/clinchem.2005.065433CrossRefPubMed Shahangian S, Labeau KM, Howerton DA: Prothrombin time testing practices: adherence to guidelines and standards. Clin Chem 2006, 52: 793-794. 10.1373/clinchem.2005.065433CrossRefPubMed
10.
go back to reference Asmis LM, Alberio L, Angelillo-Scherrer A, Korte W, Mendez A, Reber G, Seifert B, Stricker H, Tsakiris DA, Wuillemin WA: Rivaroxaban: Quantification by anti-FXa assay and influence on coagulation tests: a study in 9 Swiss laboratories. Thromb Res 2012, 129: 492-498. 10.1016/j.thromres.2011.06.031CrossRefPubMed Asmis LM, Alberio L, Angelillo-Scherrer A, Korte W, Mendez A, Reber G, Seifert B, Stricker H, Tsakiris DA, Wuillemin WA: Rivaroxaban: Quantification by anti-FXa assay and influence on coagulation tests: a study in 9 Swiss laboratories. Thromb Res 2012, 129: 492-498. 10.1016/j.thromres.2011.06.031CrossRefPubMed
11.
go back to reference Banfi G, Del Fabbro M: Biological variation in tests of hemostasis. Semin Thromb Hemost 2009, 35: 119-126. 10.1055/s-0029-1214155CrossRefPubMed Banfi G, Del Fabbro M: Biological variation in tests of hemostasis. Semin Thromb Hemost 2009, 35: 119-126. 10.1055/s-0029-1214155CrossRefPubMed
12.
go back to reference Institute CaLS: On-stage prothrombin time (PT) test and activated partial thromboplastin time (APTT) test. In CLSI Document H47–A2. Wayne, PA: CLSI; 2008. Institute CaLS: On-stage prothrombin time (PT) test and activated partial thromboplastin time (APTT) test. In CLSI Document H47–A2. Wayne, PA: CLSI; 2008.
13.
go back to reference Thomson JM, Taberner DA, Poller L: Automation and prothrombin time: a United Kingdom field study of two widely used coagulometers. J Clin Pathol 1990, 43: 679-684. 10.1136/jcp.43.8.679PubMedCentralCrossRefPubMed Thomson JM, Taberner DA, Poller L: Automation and prothrombin time: a United Kingdom field study of two widely used coagulometers. J Clin Pathol 1990, 43: 679-684. 10.1136/jcp.43.8.679PubMedCentralCrossRefPubMed
14.
go back to reference Jennings I, Kitchen DP, Woods TA, Kitchen S, Walker ID, Preston FE: Laboratory performance in the World Federation of Hemophilia EQA programme, 2003–2008. Haemophilia 2009, 15: 571-577. 10.1111/j.1365-2516.2008.01933.xCrossRefPubMed Jennings I, Kitchen DP, Woods TA, Kitchen S, Walker ID, Preston FE: Laboratory performance in the World Federation of Hemophilia EQA programme, 2003–2008. Haemophilia 2009, 15: 571-577. 10.1111/j.1365-2516.2008.01933.xCrossRefPubMed
15.
go back to reference Meijer P, Haverkate F: An external quality assessment program for von Willebrand factor laboratory analysis: an overview from the European concerted action on thrombosis and disabilities foundation. Semin Thromb Hemost 2006, 32: 485-491. 10.1055/s-2006-947862CrossRefPubMed Meijer P, Haverkate F: An external quality assessment program for von Willebrand factor laboratory analysis: an overview from the European concerted action on thrombosis and disabilities foundation. Semin Thromb Hemost 2006, 32: 485-491. 10.1055/s-2006-947862CrossRefPubMed
16.
go back to reference Kitchen S, Jennings I, Woods TA, Kitchen DP, Walker ID, Preston FE: Laboratory tests for measurement of von Willebrand factor show poor agreement among different centers: results from the United Kingdom National External Quality Assessment Scheme for Blood Coagulation. Semin Thromb Hemost 2006, 32: 492-498. 10.1055/s-2006-947863CrossRefPubMed Kitchen S, Jennings I, Woods TA, Kitchen DP, Walker ID, Preston FE: Laboratory tests for measurement of von Willebrand factor show poor agreement among different centers: results from the United Kingdom National External Quality Assessment Scheme for Blood Coagulation. Semin Thromb Hemost 2006, 32: 492-498. 10.1055/s-2006-947863CrossRefPubMed
17.
go back to reference Cuker A, Ptashkin B, Konkle BA, Pipe SW, Whinna HC, Zheng XL, Cines DB, Pollak ES: Interlaboratory agreement in the monitoring of unfractionated heparin using the anti-factor Xa-correlated activated partial thromboplastin time. J Thromb Haemost 2009, 7: 80-86. 10.1111/j.1538-7836.2008.03224.xCrossRefPubMed Cuker A, Ptashkin B, Konkle BA, Pipe SW, Whinna HC, Zheng XL, Cines DB, Pollak ES: Interlaboratory agreement in the monitoring of unfractionated heparin using the anti-factor Xa-correlated activated partial thromboplastin time. J Thromb Haemost 2009, 7: 80-86. 10.1111/j.1538-7836.2008.03224.xCrossRefPubMed
18.
go back to reference Tripodi A, Chantarangkul V: Performance of quantitative D-dimer methods: results of the Italian external quality assessment scheme. J Thromb Haemost 2007, 5: 184-185. 10.1111/j.1538-7836.2006.02252.xCrossRefPubMed Tripodi A, Chantarangkul V: Performance of quantitative D-dimer methods: results of the Italian external quality assessment scheme. J Thromb Haemost 2007, 5: 184-185. 10.1111/j.1538-7836.2006.02252.xCrossRefPubMed
19.
go back to reference Meijer P, Verbruggen B: The between-Laboratory Variation of Factor VIII Inhibitor Testing: The Experience of the External Quality Assessment Program of the ECAT Foundation. Semin Thromb Hemost 2009, 35: 786-793. 10.1055/s-0029-1245111CrossRefPubMed Meijer P, Verbruggen B: The between-Laboratory Variation of Factor VIII Inhibitor Testing: The Experience of the External Quality Assessment Program of the ECAT Foundation. Semin Thromb Hemost 2009, 35: 786-793. 10.1055/s-0029-1245111CrossRefPubMed
20.
go back to reference Kitchen S, Jennings I, Preston FE, Kitchen DP, Woods TA, Walker ID: Interlaboratory variation in factor VIII:C inhibitor assay results is sufficient to influence patient management: data from the UK national quality external assessment scheme for blood coagulation. Semin Thromb Hemost 2009, 35: 778-785. 10.1055/s-0029-1245110CrossRefPubMed Kitchen S, Jennings I, Preston FE, Kitchen DP, Woods TA, Walker ID: Interlaboratory variation in factor VIII:C inhibitor assay results is sufficient to influence patient management: data from the UK national quality external assessment scheme for blood coagulation. Semin Thromb Hemost 2009, 35: 778-785. 10.1055/s-0029-1245110CrossRefPubMed
21.
go back to reference Favaloro EJ, Bonar R, Kershaw G, Mohammed S, Duncan E, Marsden K, Committee RHQH: Laboratory identification of factor VIII inhibitors in the real world: the experience from Australasia. Haemophilia 2010, 16: 662-670.PubMed Favaloro EJ, Bonar R, Kershaw G, Mohammed S, Duncan E, Marsden K, Committee RHQH: Laboratory identification of factor VIII inhibitors in the real world: the experience from Australasia. Haemophilia 2010, 16: 662-670.PubMed
22.
go back to reference Cunningham MT, Olson JD, Chandler WL, Van Cott EM, Eby CS, Teruya J, Hollensead SC, Adcock DM, Allison PM, Kottke-Marchant KK, Smith MD: External quality assurance of fibrinogen assays using normal plasma: results of the 2008 College of American Pathologists proficiency testing program in coagulation. Arch Pathol Lab Med 2008, 2012(136):789-795. Cunningham MT, Olson JD, Chandler WL, Van Cott EM, Eby CS, Teruya J, Hollensead SC, Adcock DM, Allison PM, Kottke-Marchant KK, Smith MD: External quality assurance of fibrinogen assays using normal plasma: results of the 2008 College of American Pathologists proficiency testing program in coagulation. Arch Pathol Lab Med 2008, 2012(136):789-795.
23.
go back to reference Jennings I, Kitchen DP, Woods T, Kitchen S, Walker ID: Differences between multifibrin U and conventional Clauss fibrinogen assays: data from UK National External Quality Assessment Scheme surveys. Blood Coagul Fibrinolysis 2009, 20: 388-390. 10.1097/MBC.0b013e328329e446CrossRefPubMed Jennings I, Kitchen DP, Woods T, Kitchen S, Walker ID: Differences between multifibrin U and conventional Clauss fibrinogen assays: data from UK National External Quality Assessment Scheme surveys. Blood Coagul Fibrinolysis 2009, 20: 388-390. 10.1097/MBC.0b013e328329e446CrossRefPubMed
24.
go back to reference Tripodi A, Chantarangkul V, Legnani C, Fronton R, Testa S: Discrepancy of the international normalized ratio observed in the external quality assessment survey: a cause for concern. J Thromb Haemost 2012, 10: 714-716. 10.1111/j.1538-7836.2012.04628.xCrossRefPubMed Tripodi A, Chantarangkul V, Legnani C, Fronton R, Testa S: Discrepancy of the international normalized ratio observed in the external quality assessment survey: a cause for concern. J Thromb Haemost 2012, 10: 714-716. 10.1111/j.1538-7836.2012.04628.xCrossRefPubMed
25.
go back to reference van den Besselaar AM, Haas FJ, van der Graaf F, Kuypers AW: Harmonization of fibrinogen assay results: study within the framework of the Dutch project ‘Calibration 2000’. Int J Lab Hematol 2009, 31: 513-520. 10.1111/j.1751-553X.2008.01070.xCrossRefPubMed van den Besselaar AM, Haas FJ, van der Graaf F, Kuypers AW: Harmonization of fibrinogen assay results: study within the framework of the Dutch project ‘Calibration 2000’. Int J Lab Hematol 2009, 31: 513-520. 10.1111/j.1751-553X.2008.01070.xCrossRefPubMed
Metadata
Title
Variability between laboratories performing coagulation tests with identical platforms: a nationwide evaluation study
Authors
Michael Nagler
Lucas M Bachmann
Lorenzo Alberio
Anne Angelillo-Scherrer
Lars M Asmis
Wolfgang Korte
Adriana Mendez
Guido Reber
Hans Stricker
Dimitrios A Tsakiris
Walter A Wuillemin
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Thrombosis Journal / Issue 1/2013
Electronic ISSN: 1477-9560
DOI
https://doi.org/10.1186/1477-9560-11-6

Other articles of this Issue 1/2013

Thrombosis Journal 1/2013 Go to the issue